Cannabis Stock News- Investing in Cannabis and Hemp Stocks

Wednesday, August 21, 2019

Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: (TSXV: $META.V) (CSE: $EURO.C) (CSE: $HUGE.C) (CSE: $CURA.C) (CSE: $TIUM.C)

Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: (TSXV: $META.V) (CSE: $EURO.C) (CSE: $HUGE.C) (CSE: $CURA.C) (CSE: $TIUM.C)

Delta, Kelowna, BC –August 21, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s edition of Investorideas.com potcasts^CM - cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2019/082119-StocksToWatch.mp3

Read this in full at https://www.investorideas.com/news/2019/cannabis-potcasts/08211META-EURO-HUGE-CURA-TIUM.asp

Hear Investor ideas cannabis potcast on iTunes

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

In today’s podcast we look at a few early announcements.

But first, in recent news, the federal government has become overwhelmed with the large amount of cannabis research applications that have been steadily coming in since last October.

As of last month, there were 251 applicants waiting in the queue for approval, and scientists are becoming increasingly irritated with the stagnancy of the process, which is currently subject to waits lasting months at a time.

“It’s incredibly slow—much slower than it used to be,” University of Lethbridge plant geneticist Igor Kovalchuk, told Science magazine. “October 17, 2018, is when things slowed down tremendously.”

Federal legalization produced an instant flood of cannabis research applications for Health Canada which they are attempting to manage on top of those applications for cultivation, processing, retail and other aspects of the strictly-regulated industry that require the federal agency’s approval.

Health Minister Ginette Petitpas-Taylor announced in May that it is investing in its own research projects relating to the drug.

“We are investing in research to provide the evidence needed to maintain policies for cannabis use that protect the health and safety of Canadians,” she said.

National Access Cannabis Corp. (TSXV: META), Canada's largest cannabis retailer¹, today provided investors with a corporate and retail sales update. The Company is successfully executing on its growth strategy and has achieved over $50 million in retail sales since legalization, with cumulative gross margin in excess of 31%. The Company is targeting to have 40 operating stores by the end of calendar 2019.

"NAC is rapidly growing its store count and revenue," said Mark Goliger, CEO of NAC. "We have been granted 10 licenses in Alberta since the ending of the moratorium on May 31^st, and we expect positive movement with our licence applications in British Columbia. We now have 30 stores open, with another 5 stores licensed and in development. We expect continued revenue momentum as we roll out improved and streamlined store designs to enhance customer experience. With the recent filing of our final base shelf prospectus to provide us with flexible access to capital, we are confident in our ability to execute on our strategic growth initiatives to continue our leadership position in Canadian cannabis retail."

The Company's current portfolio of 35 licensed locations is split as follows:

● 25 NewLeaf Cannabis™ stores in Alberta

● 9 Meta Cannabis Supply Co.™ stores in Manitoba

● 1 Meta Cannabis Supply Co.™ store in Saskatchewan

FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) today announced the launch of its online ordering system for the direct fulfillment of medicinal cannabis orders. Through its wholly-owned subsidiary, FV Pharma Inc., clients with a prescription from a medical practitioner or a registration number with Health Canada can now place an order online for dried cannabis on FVPharma.com.

"The launch of a functional online ordering portal to fulfill prescriptions for medicinal cannabis is a very important milestone for FSD Pharma. Since receipt of our Sale for Medical Purposes license earlier in June, we are now open for registration online to a wider client base and we are pleased that patients have already begun to use our user friendly website," said Raza Bokhari, MD, FSD Executive Co-Chairman & Chief Executive Officer.

"I want to personally congratulate the FSD Pharma team in helping the company advance into this important phase; we still have many more successful chapters to write together," concluded Dr. Bokhari.

EuroLife Brands Inc. (CSE: EURO) (OTCPK: CANVF), a leading global markets cannabis brand empowering the medical, recreational and CPG cannabis industry worldwide, announced that its corporate rebranding and repositioning within the cannabis industry has been completed with the launch of its EuroLifeBrands.com company website and corporate refocus.

"With our corporate rebrand complete, we are free to focus all efforts on continuing to grow the EuroLife cannabis brand across Europe and South America with a determination on new opportunities, strategic mergers and acquisitions to build shareholder value," said Shawn Moniz, Chief Executive Officer, EuroLife Brands Inc. "We expect to quickly become a leader in the burgeoning CPG CBD market across Europe by leveraging our rich repository of unbiased and physician-backed original educational content alongside our in-depth consumer data and analytics."

Demonstrating the Company's commitment to providing accessible cannabis education, its Director of Strategy and Education Daniel Davidzon was recently published in the National Post arguing for the crucial need for evidence-based cannabis education for cannabis consumers across Canada and the world. With so many cannabis-curious consumers confused over what treatments, products and services available to them, the need for an education-driven marketplace has grown exponentially and EuroLife is poised to lead the market with its repository of over 400 physician-backed and educator-approved articles and over 70 courses in its education platform.

The EuroLife executive team devoted a significant amount of time over the last quarter quantifying strategic partners across Europe in both the cannabis sector and other industries to determine the organization's realignment and strengthen the brand's presence across the continent. A recent report from the Brightfield Group, a leading market intelligence firm for the legal CBD and cannabis industries, estimated the European CBD market at USD $318 million in 2018, with the expectation of booming growth over 400 percent through 2023. The global CBD market is projected to grow from USD $1 billion in 2018 to USD $16 billion by 2026, according to Fior Market Research, a futuristic market intelligence company.

While the Company shifts its European and South American activities toward the CBD market, the anchor of its North American operations remains its Canadian and U.S.-focused digital cannabis education resource Cannvas.Me and Cannvas.Pet.

Eurolife is also announced the formation of a new Veterinary Advisory Board to guide educational content for its Canvas.Pet platform, as well as two new culinary-focused appointments to its Cannabis Sciences Advisory Board.

Award-winning veterinarian Dr. Scott Bainbridge has been appointed as the Veterinary Advisory Board lead, bringing with him nearly 20 years of veterinary expertise across a range of practices. Dr. Bainbridge and his team of eight vets diagnose approximately 15,000 cases every year at his Dundas West Animal Hospital (DWAH) in Toronto. Recently honoured by the Ontario Veterinary Medical Association with a lifetime achievement for public service, Dr. Bainbridge makes regular appearances on radio and television, appearing on CP24's Animal House Calls as a regular contributor and acts as the expert veterinarian for Canadian Living Magazine.

Award-winning author and culinary herbalist Pat Crocker, and founder of Upward Cannabis Kitchen, Carlton Bone, join the Cannabis Sciences Advisory Board to provide insights into evidence-based education around cannabis-infused edibles and beverages while contributing potential consumer packaged goods offerings to the EuroLife Marketplace platform.

A prolific author and in-demand speaker, Pat Crocker has written over 22 cookbooks. Her latest project is Healing Cannabis Edibles, a revolutionary cookbook and healing guide encouraging informed decisions around cannabis consumption to potentially improve certain health conditions. Ms. Crocker's books have sold hundreds of thousands of copies and have been featured on bestseller's lists across North America, including The Globe and Mail.

The founder of Portland, Oregon-based Upward Cannabis Kitchen, Carlton Bone has a passion for crafting high quality cannabis products and has developed a tea-based cannabis beverage line. Carlton also acts as the Chief Information Officer for Dr. Melanie Bone, a physician and educator with a focus on the intersection of cannabis and women's health care. Recently, the two collaborated on creating cannabis-infused suppositories to support anyone who needs relief due to chronic pain or additional comfort during their cycle.

Cansortium Inc. (CSE: TIUM-U) (OTCQB: CNTMF), a vertically-integrated, global provider of premium-quality medical cannabis operating under the Fluent™ brand, announced today that it will begin trading today on the OTCQB Venture Market under the ticker "CNTMF". This is an upgrade from the Company's previous classification on the Pink Open Market.

Cansortium Chief Executive Officer Jose Hidalgo emphasized, "We are very pleased to begin trading on the OTCQB Venture Market less than five months after our initial public offering on the Canadian Securities Exchange, adding valuable visibility and additional liquidity for the benefit of our shareholders. We are intently focused on executing our growth strategy by expanding our cultivation capacity and dispensary platform in our home state of Florida and establishing our Fluent™ brand of cannabis products as a leader in each market where we choose to compete."

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF), a leading vertically integrated cannabis operator in the United States, today announced it has obtained eligibility with The Depository Trust Company ("DTC") for its shares listed on the OTCQX. DTC is a subsidiary of the Depository Trust & Clearing Corporation, a U.S. company that manages the electronic clearing and settlement of publicly traded companies. DTC eligibility provides cost benefits for investors and brokers trading in our securities in the United States.

"Receiving DTC eligibility will allow for a more friendly trading experience for our current and future shareholders," said Joseph Lusardi, CEO of Curaleaf. "Shareholders of Curaleaf will now be able to electronically transfer shares between brokerages in the U.S. and with this improved access to our shares, we expect a positive impact to the liquidity and demand for our stock."

Investor ideas reminds all listeners to read our disclaimers and disclosures on the

Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment

Sign up to get the news alerts including the daily podcast and transcript for Investor ideas podcasts

Subscribe to the new cannabis podcast series:

https://www.investorideas.com/rss/feeds/Podcasts-Cannabis.xml

Or visit https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

Follow us on Social Media

https://www.facebook.com/Investorideaspotcasts/

https://twitter.com/MJInvestorIdeas

https://www.instagram.com/potcasts_investorideas/

Download our Mobile App for iPhone and Android

Contact Investorideas.com

800-665-0411

Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directories

#CBD Product Sales Snapshot Looking at the US and Globally-(OTC: $HIPH) (OTC: $EDXC) (OTC: $CANN) (OTC: $MJNA)

#CBD Product Sales Snapshot Looking at the US and Globally-(OTC: $HIPH) (OTC: $EDXC) (OTC: $CANN) (OTC: $MJNA)

Point Roberts WA, Delta, BC – August 21, 2019 - Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot looking at the recently reported growth in CBD product sales and how this is now painting a more accurate picture of the CBD market.

In recent news, New York-based Nielsen estimated total sales of all legalized cannabis, which includes C.B.D. products, reached $8 billion in the United States in 2018.

“As legal restrictions are loosened, the process of bringing a hemp C.B.D. product to market, including the leveraging of mainstream distribution channels, could soon mirror that of other C.P.G. (consumer packaged goods) products,” Nielsen said. “From over-the-counter medications, to cosmetics, pet care and even products throughout the traditional food and beverage space, the future potential of hemp-based C.B.D. could impact billions in C.P.G. sales across categories.”

CBD has been a rampant news topic for the past year and has even overshadowed the cannabis (high THC plant) industry in some regards. However, due to lack of clarity from the FDA, sales have yet to reach the critical mass many have been anticipating. This is starting to change as more companies learn to navigate these complex regulations, product quality and consistency improves and for some, as brand awareness takes off. Now recent financial results give evidence to an overall increase in CBD product sales that are finally generating real revenues, both in the US and abroad.

American Premium Water Corporation (OTC: HIPH) recently announced that it has secured a contract through its UK subsidiary, which will generate over $833,000 of topline revenue. This is the largest contract for the Company to date, and puts the Company on a solid track to exceed its previously issued 2019 revenue guidance of $1 million.

Read this in full at https://www.investorideas.com/news/2019/cannabis/08211CBDProductSales.asp

American Premium Water Corporation CEO, Ryan Fishoff stated, “I’m happy to announce that the Company has secured its largest contract to date, adding over $833,000 in top line revenue. The Company is making strides towards becoming the market leader in premium CBD infused consumer products. We have been making incremental progress towards bringing our products to market and generating revenue; shareholders are beginning to see the fruits of management’s labors. There is still a lot of work to be done; the Company has an ambitious business plan that it is focused on executing. There is a lot of business in the pipeline that the Company is working on closing to generate more sales and form partnerships that will create long-term growth to the Company’s top and bottom line. I am headed to London this week to ensure that the Company completes the payment process for this contract so that we can add it to the 2nd quarter filings.”

The contract was executed in the 2nd quarter of 2019. The payment, which originated from the UK, had not settled at the time of filing deadline. After consulting with the Company’s retained accountants, it was determined that it would be in the Company’s best interests to file 2nd quarter financials to remain compliant with OTC Markets and the Company will amend the filing upon completion of the clearing process in accordance with Generally Accepted Accounting Principles (“GAAP”).

Mr. Fishoff continued, “Aside from work on this contract and the two-container order that we announced last week that should be shipping out next month to the UK, the Company has been focusing on Canyon Create, investing more capital and resources this quarter into expanding distribution of Vanexxe, which is currently available on Wal-Mart.com. This ground breaking product fulfills a need for an affordable and effective cosmetic treatment for unsightly varicose veins, which before its launch didn’t exist in the marketplace. The Company is also set to launch its Prickly Pear acne cream, which uses CBD and CBG as its activating agents. The Company feels this product has the potential to become a market leader relatively quickly. We’re excited for Canyon and the Company’s other initiatives that will be picking up steam in the 2nd half of the year. I look forward to keeping the investor and shareholder community informed as I am able to update everyone accordingly.”

LALPINA CBD water can now be purchased online at https://www.singleseed.com/product/lalpina-cbd-water-6-pack/

CBD Unlimited, Inc., formerly known as Endexx Corporation (OTC: EDXC), a provider of innovative phytonutrient-based food and nutritional products, recently reported year over year revenue growth for its third quarter of fiscal 2019. For the three months ended June 30, 2019, the Company generated over $335,000 in sales, which represents an increase of 52% year over year, and nine months year-to-date $1,252,880 a 108% increase.

“Our third quarter of fiscal 2019 showcases our accelerated annual growth rate and investment in the long-term success of CBD Unlimited. Our team continues to innovate and exceed expectations as we build strong momentum to finish the fiscal year. Earlier, in December, we forecasted that we would be in 5,000 stores by the end of calendar 2019. We are positioned to surpass this number near term. The company will continue to invest in inventory, innovation and scalability, delivering and executing the business plan,” commented CEO & Chairman, Todd Davis. “As we look to the rest of the year, we expect to continue this growth trajectory as we increase our store count exponentially. As we scale aggressively, we continue to watch and listen to the pending FDA suggested guidelines closely. Additionally, we look to efficiently educate the consumer on our CBD products. We look forward to executing continued growth for the remainder of fiscal 2019 and on to 2020.”

As mentioned above, CBD is drawing in a lot of interest, including that of many more THC focused cannabis companies looking to ride the CBD wave. Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, recently announced that the Company has begun manufacturing operations under an industrial hemp processor license.

This processor license will allow Medical Marijuana, Inc. to freely store, handle and convert industrial hemp into a marketable form. This will enable the company to continue implementing its soil to sale plan, including processing its own raw material and manufacturing finished goods within the new facility.

“Operating under this license is a big step for our Company and a great sign for the future of our domestic operations,” said Medical Marijuana, Inc. CEO, Dr. Stuart Titus. “The 2018 Farm Bill has allowed us to grow our processing and manufacturing capabilities as well as drive the global supply chain of high-quality hemp.”

General Cannabis Corp (OTC: CANN), the comprehensive national resource to the regulated cannabis industry, also recently announced their financial results for the quarter ended June 30, 2019.

“We have surpassed $1 million in revenue for the fifth consecutive quarter, with a 34% increase in year-to-date revenue in 2019 compared to 2018,” said Brian Andrews, Chief Financial Officer of General Cannabis. “During the first six months of the year, we have increased our focus on securing significant consulting contracts in emerging markets across the country and providing wholesale products to new and existing customers. Both efforts have resulted in significant increases in Operations revenue compared to the prior year. Security revenues were negatively impacted by customers deciding to forego guard services and slower than expected growth in California. We continue to explore additional revenue streams within the Security segment, such as camera monitoring design and installation, and product transport. In response to lower revenues from Chiefton, within our Consumer Goods segment, over the course of the last three months we have eliminated annualized overhead by approximately $350,000 in order to better match our cost structure to estimated potential revenues.”

Michael Feinsod, Chief Executive Officer and Executive Chairman of General Cannabis, stated, “It was a busy quarter with a focus on our existing businesses while making significant other operational and business improvements as described in this release. We expect these steps to reap benefits over the near term.

“We have recently opened our new CBD store and e-commerce website, STOA Wellness, which offers a curated collection of quality products designed for high performance athletes. We strive to offer high quality products derived from sustainably sourced plants. We believe this sets us apart and offers our customers a unique experience. We trust these factors will generate growing Consumer Goods revenue through the remainder of the year.

“In addition to growing our existing lines of business, we are excited to embark in the coming months on multiple potential acquisitions we have announced as HB-1090 is implemented. As of today, we have entered into non-binding term sheets for approximately 45,000 square feet of cultivation space, a processing facility and adult use (recreational) dispensaries. Our operating history and Colorado experience have proven to be strong attractions as we engage with potential Colorado partners. To date, each of the proposed transactions would keep existing management teams in place. We look forward to moving forward with these transactions and integrating these new teams into our General Cannabis family. We believe that upon completion, these strategic acquisitions will create synergistic opportunities that will allow us to leverage our skill sets to help our customers succeed.”

With more real-time sales and revenue data coming to the forefront each week, investors and consumers now have a better assessment of real CBD demand and sales and a more accurate picture of how the true CBD market is coming into focus. We can expect to see more sales data over the coming months, especially once the FDA does release clearer guidelines for the industry, expected later this year.

For investors following cannabis stocks, Investor Ideas has created a stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana/Hemp Stocks

About Investorideas.com - News that Inspires Big Investing Ideas

https://www.investorideas.com/About/

Follow us on Cannabis Social Media

https://www.facebook.com/Investorideaspotcasts/

https://twitter.com/MJInvestorIdeas

https://www.instagram.com/potcasts_investorideas/

Download our Mobile App for iPhone and Android

Disclaimer/Disclosure: Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

Disclosure: this news article featuring HIPH is a paid for news release on Investorideas.com by a third party Learn more about costs and our services for articles and podcasts (two thousand) https://www.investorideas.com/News-Upload/

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Contact Investorideas.com

800-665-0411

Get more Marijuana, hemp & cannabis stock investor ideas- news, articles, podcasts and stock directories

Tuesday, August 20, 2019

Investorideas.com - Brigadier (TSXV:BRG.H) Announces Execution of Definitive Agreements to Become Asia / China CBD Market Focused Investment Issuer

Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: (CSE: $CURA.C) (CSE: $TTT.C) (TSX: $WEED.CA) (NYSE: $CGC) (TSXV: $KHRN.V) (CSE: $CBDT.C) (CSE: $FFNT.C)

Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: (CSE: $CURA.C) (CSE: $TTT.C) (TSX: $WEED.CA) (NYSE: $CGC) (TSXV: $KHRN.V) (CSE: $CBDT.C) (CSE: $FFNT.C)

Delta, Kelowna, BC –August 20, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s edition of Investorideas.com potcasts^CM - cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2019/082019-StocksToWatch.mp3

Read this in full at

https://www.investorideas.com/news/2019/cannabis-potcasts/08201CURA-TTT-WEED-CGC-KHRN-CBDT-FFNT.asp

Hear Investor ideas cannabis potcast on iTunes

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

In today’s podcast we look at a few early announcements.

Curaleaf Holdings Inc. (CSE: CURA) (OTC: CURLF) launched its initiative with the Veterans Cannabis Project (VCP), an organization that advocates for legal and supported access of medical cannabis for veterans through the Department of Veterans Affairs, in Oregon.

Customers can now purchase a custom-designed Veterans Cannabis Project pre-roll product, with a portion of all proceeds benefiting the VCP. Each box includes five pre-rolls (total of 2.5 grams) of UKU flower – one of Oregon's top selling flower brands* – and will be available for $13. Images can be downloaded here.

"Raising awareness of veterans' access to cannabis is an important issue for Curaleaf," said Tim Fitzpatrick, President of Curaleaf Oregon. "Curaleaf can play an important role by educating veterans and consumers on how cannabis may be of great benefit for veterans. We are proud to be able to support our veterans as they look to improve their quality of life."

"As a veteran myself, I was grateful to be made aware of how medical cannabis can help me," said Doug Distaso, VCP's Executive Director. "There are millions of veterans, but federal law makes it illegal for Veteran Health Administration physicians to recommend cannabis as a treatment. This is something we are looking to change. Our partnership with Curaleaf will help veterans gain legal access to cannabis."

Curaleaf officially launched the Veterans Cannabis Project initiative in Maryland earlier this year; products are currently available for purchase in Maryland, Maine and Arizona. The company will continue rolling out the program at Curaleaf dispensaries across the United States. The Veterans Cannabis Project product will also be available for purchase at other cannabis operators later this year.

TruTrace Technologies Inc. (CSE: TTT) (OTCQB: TTTSF), creator of the first fully-integrated blockchain platform that registers and tracks intellectual property for the cannabis industry, today announced that it has signed a letter of intent to establish a strategic working relationship with Anandia Laboratories Inc. The two companies intend to collaborate on an integrated testing solution in relation to TruTrace's development of a blockchain-secured traceability ecosystem for the cannabis industry.

Anandia is considered an industry leader in science, genetics, and independent cannabis product testing. Pursuant to the LOI, Anandia will serve as a primary analytical and genetic testing partner in the TruTrace ecosystem. The parties will also explore ways to work together on rapidly expediting and optimizing the testing processes under the Cannabis Act (Canada) as set forth by Health Canada, as well as evolving genetic testing practices in the cannabis industry.

Anandia is also expected to be one of the featured testing facilities in the Shoppers Drug Mart and TruTrace Technologies medical cannabis verification pilot program. As announced by Shoppers at the second annual World Cannabis Congress, the Pilot Program is built on TruTrace's proprietary StrainSecure™ platform, which focuses on testing and verification to confirm the origin, authenticity and quality assurance of cannabis products.

"We are very excited to have Anandia join us as a testing partner in the StrainSecure ecosystem," said TruTrace Technologies CEO Robert Galarza. "Its genetic testing expertise and capabilities combined with its full range of analytical testing makes it a 'one-stop shop' that we expect will play an important role in our traceability program."

"Establishing a comprehensive traceability program is an important step for the cannabis industry in offering full transparency and verification for patients and consumers," said Dr. John Coleman, Anandia President and Co-Founder. "We are supportive of these objectives and look forward to working with TruTrace, Shoppers and others in the Pilot Program."

Under the StrainSecure program, the TruTrace team collects plant testing data and performs genomic verification in plant batches which are then registered in a blockchain-enabled database for intellectual property protection and strain validation. All information gathered from the plants, including their molecular and chemical makeup, can be tracked via the program.

Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) announced that it has received a licence from Health Canada for its KeyLeaf Life Sciences facility in Saskatoon, Saskatchewan. Including the Smiths Falls site and the recently licensed BC Tweed extraction site, Canopy Growth now operates three significant extraction assets to support the throughput required for large scale value-add product development.

Canopy Growth recently retrofitted the now fully licensed KeyLeaf facility in Saskatchewan, a company with over 50 years of experience in the extraction industry. This facility is expected to be online in the Fall of 2019 and has the capacity to extract up to 5,000 kilograms of hemp or cannabis biomass per day. The application for the licence was submitted under KeyLeaf's previous name, POS Management Corp. and will be updated in due course. The newly-licensed extraction platform is located in close proximity to Canopy Growth's large-scale outdoor hemp and cannabis grow operations. The Company looks forward to the additional capacity increasing production efficiency, augmenting output volume, and ultimately reducing operational costs for value-add products set to be rolled out in the Canadian recreational and medical markets at the end of calendar year 2019.

"With this milestone, we are executing against the vision of making strategic investments today in order to deliver results over the long term," said Mark Zekulin, CEO, Canopy Growth. "This licence will ensure we have the supply of extraction inputs for the medical, CBD, and recreational markets, especially the next generation of value-add, high margin cannabis products here in Canada."

The KeyLeaf facility, and broader extraction infrastructure that has been recently licensed, will complement the Company's indoor, greenhouse, and outdoor cannabis and hemp growing operations on the one side, and its value-add beverages, vapes, softgels and edibles infrastructure on the other side. The licensing of these facilities brings the Company one major step closer to completing its Canadian build-out, and also represents a blueprint model for international expansion as global market demand dictates.

Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQB: KHRNF) announced today that its shares have received Depository Trust Company full-service eligibility in the United States. DTC eligibility is expected to simplify the process of trading and transferring of the Company's common shares in the United States.

DTC is a subsidiary of the Depository Trust & Clearing Corp., a U.S. company that manages the electronic clearing and settlement of publicly traded companies. DTC eligibility permits shares of Khiron to be distributed, settled and serviced through DTC's automated processes, leveraging the efficiencies created through the electronic clearing and settlement of securities. DTC services provide cost benefits for investors and brokers trading Canadian securities in the United States.

EMPOWER CLINICS INC. (CSE: CBDT) (OTC: EPWCF) today announced that its common shares began trading on the OTCQB Venture Market at the opening of the market, today on August 20^th, 2019 under the stock symbol (OTC: EPWCF).

Empower Clinics Inc. (OTCQB: EPWCF) now trades on the OTCQB Venture Market for early stage and developing U.S. and international companies. Companies are current in their reporting and undergo an annual verification and management certification process. Investors can find Real-Time quotes and market information for the company on http://www.otcmarkets.com.

In addition, Empower's shares will continue to be listed on the Canadian Securities Exchange (CSE) under the ticker symbol "CBDT," as well as on the Frankfurt Stock Exchange under the ticker symbol "8EC."

"Our listing on the OTCQB Venture Market in the United States complements Empower's listings on the Canadian and Frankfurt Stock Exchanges, respectively, broadening our investment base as we accelerate our growth strategy in the global medical cannabis and wellness sectors," said Steven McAuley, Empower CEO. "This is a timely milestone, as we have a robust pipeline of activity tied to product development, business development, M&A and, overall company expansion."

4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) announced that it began trading on the OTC Market Group's OTCQX^® Best Market under the new ticker symbol "FFNTF" at market open, today on August 20, 2019.

4Front is a cannabis company designed for long-term success and built upon battle-tested operating capabilities, experienced and aligned leadership, a strategic asset base, and a commitment to being a magnet for talent. From plant genetics to the cannabis retail experience, 4Front's team can apply expertise across the value chain. 4Front has invested heavily to assemble a comprehensive collection of management skills and hands-on operating expertise to capitalize on the unique growth opportunity being afforded by the increased legalization of cannabis. For more information, visit 4Front's website.

Investor ideas reminds all listeners to read our disclaimers and disclosures on the

Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment

Sign up to get the news alerts including the daily podcast and transcript for Investor ideas podcasts

Subscribe to the new cannabis podcast series:

https://www.investorideas.com/rss/feeds/Podcasts-Cannabis.xml

Or visit https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

Follow us on Social Media

https://www.facebook.com/Investorideaspotcasts/

https://twitter.com/MJInvestorIdeas

https://www.instagram.com/potcasts_investorideas/

Download our Mobile App for iPhone and Android

Contact Investorideas.com

800-665-0411

Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directories

Monday, August 19, 2019

Investorideas.com - Cannabis Stock News: Harvest One (TSXV: HVT; OTCQX: HRVOF) Launches New Satipharm CBD Oil

Investorideas.com - Cannabis Stock News: Harvest One (TSXV: HVT; OTCQX: HRVOF) Launches New Satipharm CBD Oil

Get the latest Cannabis and Hemp stock news from www.investorideas.com

Investorideas.com - Cannabis Stock News: Dixie Brands' (CSE: DIXI.U) (OTCQX: $DXBRF) Aceso Hemp expands distribution footprint into California and Nevada with Power Distribution LLC

Investorideas.com - Cannabis Stock News: Dixie Brands' (CSE: DIXI.U) (OTCQX: $DXBRF) Aceso Hemp expands distribution footprint into California and Nevada with Power Distribution LLC

Get the latest Cannabis and Hemp stock news from www.investorideas.com

Investorideas.com - Cannabis Stock News: Valens (TSXV: VGW) (OTCQX: VGWCF) Begins Trading on the OTCQX Best Market in the U.S.

about Investorideas.com

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .